Oruka Therapeutics
ORKAAlgoritmens signaler
- ›Starkt 3m-momentum (+38.2%)
- ›Starkt 6m-momentum (+126.5%)
- ›Starkt 12m-momentum (+477.1%)
- ›Hög volatilitet (55% årlig)
- ›+528% från 52v-botten
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsOruka Therapeutics CEO Lawrence Klein sells $234,680 in ORKA stock By Investing.com - Investing.com South Africa
9 h sedanOruka Therapeutics CEO Lawrence Klein sells $234,680 in ORKA stock By Investing.com Investing.com South Africa
Investing.com South AfricaOruka Therapeutics COO Sandler sells $86,713 in common stock - Investing.com
1 d sedanOruka Therapeutics COO Sandler sells $86,713 in common stock Investing.com
Investing.comIs Oruka Therapeutics (ORKA) Fully Valued As Psoriasis Pipeline Hopes Face A Pullback? - simplywall.st
3 d sedanIs Oruka Therapeutics (ORKA) Fully Valued As Psoriasis Pipeline Hopes Face A Pullback? simplywall.st
simplywall.stMorgan Stanley's New York healthcare conference includes Oruka - stocktitan.net
2026-09-09Morgan Stanley's New York healthcare conference includes Oruka stocktitan.net
stocktitan.netORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know - finance.yahoo.com
2026-08-28ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know finance.yahoo.com
finance.yahoo.comOruka Therapeutics Is Priced For Perfection - It’s Time To Cash Out (NASDAQ:ORKA) - Seeking Alpha
2026-08-03Oruka Therapeutics Is Priced For Perfection - It’s Time To Cash Out (NASDAQ:ORKA) Seeking Alpha
Seeking AlphaOruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock? - finance.yahoo.com
2026-06-12Oruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock? finance.yahoo.com
finance.yahoo.comAn Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million - The Motley Fool
2026-05-31An Oruka Therapeutics (ORKA) Insider Sold 105,000 Shares Worth $6.2 Million The Motley Fool
The Motley FoolSHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate ABIO, MODN, DPSI, AIRC
2024-06-05SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate ABIO, MODN, DPSI, AIRC PR Newswire NEW YORK, June 5, 2024 NEW YORK , June 5, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights
ARCA biopharmaPR NewswireShareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka
2024-06-05Shareholder Alert: Ademi LLP investigates Disclosure Issues involving ARCA biopharma, Inc.'s Transaction with Oruka PR Newswire MILWAUKEE, June 4, 2024 MILWAUKEE , June 4, 2024 /PRNewswire/ -- Adem
ARCA biopharmaPR NewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF
2024-05-23SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF PR Newswire NEW YORK, May 23, 2024 NEW YORK , May 23, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law f
ARCA biopharmaPR NewswireKuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm
2024-05-22Kuehn Law Encourages ABIO, SQSP, SSB, and HMNF Investors to Contact Law Firm PR Newswire NEW YORK, May 22, 2024 NEW YORK , May 22, 2024 /PRNewswire/ -- Kuehn Law , PLLC, a shareholder litigation la
ARCA biopharmaPR NewswireARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
2024-05-10Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of ARCA biopharma, Inc. (the “Company”) (Nasdaq
ARCA biopharmaBusiness WireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO
2024-04-10SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO PR Newswire NEW YORK, April 10, 2024 NEW YORK , April 10, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law
ARCA biopharmaPR NewswireSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO
2024-04-10SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO PR Newswire NEW YORK, April 9, 2024 NEW YORK , April 9, 2024 /PRNewswire/ -- Montever
ARCA biopharmaPR NewswireKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
2024-04-05Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm PR Newswire NEW YORK, April 5, 2024 NEW YORK , April 5, 2024 /PRNewswire/ -- Kuehn Law , PLLC, a shareholder litigation l
ARCA biopharmaPR Newswire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.